303 related articles for article (PubMed ID: 22006005)
41. Molecular Identification, Antifungal Susceptibility Testing, and Mechanisms of Azole Resistance in
Rivero-Menendez O; Soto-Debran JC; Medina N; Lucio J; Mellado E; Alastruey-Izquierdo A
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285229
[TBL] [Abstract][Full Text] [Related]
42. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
Tashiro M; Izumikawa K; Minematsu A; Hirano K; Iwanaga N; Ide S; Mihara T; Hosogaya N; Takazono T; Morinaga Y; Nakamura S; Kurihara S; Imamura Y; Miyazaki T; Nishino T; Tsukamoto M; Kakeya H; Yamamoto Y; Yanagihara K; Yasuoka A; Tashiro T; Kohno S
Antimicrob Agents Chemother; 2012 Jan; 56(1):584-7. PubMed ID: 22024829
[TBL] [Abstract][Full Text] [Related]
43. Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.
Vazquez JA; Manavathu EK
Antimicrob Agents Chemother; 2016 Feb; 60(2):1129-33. PubMed ID: 26574014
[TBL] [Abstract][Full Text] [Related]
44. The sterol C-24 methyltransferase encoding gene, erg6, is essential for viability of Aspergillus species.
Xie J; Rybak JM; Martin-Vicente A; Guruceaga X; Thorn HI; Nywening AV; Ge W; Parker JE; Kelly SL; Rogers PD; Fortwendel JR
Nat Commun; 2024 May; 15(1):4261. PubMed ID: 38769341
[TBL] [Abstract][Full Text] [Related]
45. Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis.
Pelaez T; Gijón P; Bunsow E; Bouza E; Sánchez-Yebra W; Valerio M; Gama B; Cuenca-Estrella M; Mellado E
J Clin Microbiol; 2012 Jul; 50(7):2531-4. PubMed ID: 22573589
[TBL] [Abstract][Full Text] [Related]
46.
Souza ACO; Ge W; Wiederhold NP; Rybak JM; Fortwendel JR; Rogers PD
Microbiol Spectr; 2023 Jun; 11(3):e0518822. PubMed ID: 37140376
[TBL] [Abstract][Full Text] [Related]
47. Identification and Characterization of a Novel Aspergillus fumigatus Rhomboid Family Putative Protease, RbdA, Involved in Hypoxia Sensing and Virulence.
Vaknin Y; Hillmann F; Iannitti R; Ben Baruch N; Sandovsky-Losica H; Shadkchan Y; Romani L; Brakhage A; Kniemeyer O; Osherov N
Infect Immun; 2016 Jun; 84(6):1866-1878. PubMed ID: 27068092
[TBL] [Abstract][Full Text] [Related]
48. Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles.
Nawrot U; Kurzyk E; Arendrup MC; Mroczynska M; Wlodarczyk K; Sulik-Tyszka B; Wróblewska M; Ussowicz M; Zdziarski P; Niewinska K; Brillowska-Dabrowska A
Med Mycol; 2018 Jan; 56(1):121-124. PubMed ID: 28340159
[TBL] [Abstract][Full Text] [Related]
49. Sterol Biosynthesis and Azole Tolerance Is Governed by the Opposing Actions of SrbA and the CCAAT Binding Complex.
Gsaller F; Hortschansky P; Furukawa T; Carr PD; Rash B; Capilla J; Müller C; Bracher F; Bowyer P; Haas H; Brakhage AA; Bromley MJ
PLoS Pathog; 2016 Jul; 12(7):e1005775. PubMed ID: 27438727
[TBL] [Abstract][Full Text] [Related]
50. Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.
Chowdhary A; Kathuria S; Xu J; Sharma C; Sundar G; Singh PK; Gaur SN; Hagen F; Klaassen CH; Meis JF
PLoS One; 2012; 7(12):e52871. PubMed ID: 23285210
[TBL] [Abstract][Full Text] [Related]
51. Relation of the polymorphism of cyp51A sequence and the susceptibility of Aspergillus fumigatus isolates to triazoles determined by commercial gradient test (Etest) and by reference methods.
Nawrot U; Sulik-Tyszka B; Kurzyk E; Mroczyńska M; Włodarczyk K; Wróblewska M; Basak GW; Brillowska-Dąbrowska A
Acta Biochim Pol; 2017; 64(4):631-634. PubMed ID: 29202140
[TBL] [Abstract][Full Text] [Related]
52. Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis.
Mavridou E; Bruggemann RJ; Melchers WJ; Verweij PE; Mouton JW
Antimicrob Agents Chemother; 2010 Nov; 54(11):4758-64. PubMed ID: 20733046
[TBL] [Abstract][Full Text] [Related]
53. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.
Lescar J; Meyer I; Akshita K; Srinivasaraghavan K; Verma C; Palous M; Mazier D; Datry A; Fekkar A
J Antimicrob Chemother; 2014 Dec; 69(12):3244-7. PubMed ID: 25125676
[TBL] [Abstract][Full Text] [Related]
54. Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.
Sharma C; Nelson-Sathi S; Singh A; Radhakrishna Pillai M; Chowdhary A
Fungal Genet Biol; 2019 Nov; 132():103265. PubMed ID: 31465846
[TBL] [Abstract][Full Text] [Related]
55. Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.
van der Linden JW; Camps SM; Kampinga GA; Arends JP; Debets-Ossenkopp YJ; Haas PJ; Rijnders BJ; Kuijper EJ; van Tiel FH; Varga J; Karawajczyk A; Zoll J; Melchers WJ; Verweij PE
Clin Infect Dis; 2013 Aug; 57(4):513-20. PubMed ID: 23667263
[TBL] [Abstract][Full Text] [Related]
56. Attenuation of itraconazole fungicidal activity following preexposure of Aspergillus fumigatus to fluconazole.
Liu W; Lionakis MS; Lewis RE; Wiederhold N; May GS; Kontoyiannis DP
Antimicrob Agents Chemother; 2003 Nov; 47(11):3592-7. PubMed ID: 14576123
[TBL] [Abstract][Full Text] [Related]
57. The cytochrome b
Misslinger M; Gsaller F; Hortschansky P; Müller C; Bracher F; Bromley MJ; Haas H
Metallomics; 2017 Nov; 9(11):1655-1665. PubMed ID: 29072765
[TBL] [Abstract][Full Text] [Related]
58. A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.
Mellado E; Garcia-Effron G; Alcázar-Fuoli L; Melchers WJ; Verweij PE; Cuenca-Estrella M; Rodríguez-Tudela JL
Antimicrob Agents Chemother; 2007 Jun; 51(6):1897-904. PubMed ID: 17371828
[TBL] [Abstract][Full Text] [Related]
59. First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.
Özmerdiven GE; Ak S; Ener B; Ağca H; Cilo BD; Tunca B; Akalın H
J Infect Chemother; 2015 Aug; 21(8):581-6. PubMed ID: 26048062
[TBL] [Abstract][Full Text] [Related]
60. High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?
Nabili M; Shokohi T; Moazeni M; Khodavaisy S; Aliyali M; Badiee P; Zarrinfar H; Hagen F; Badali H
J Med Microbiol; 2016 Jun; 65(6):468-475. PubMed ID: 27008655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
